Literature DB >> 19158354

C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy.

Ziyong Tang1, Bao Lu, Ellen Hatch, Steven H Sacks, Neil S Sheerin.   

Abstract

Tubulointerstitial inflammation and progressive fibrosis are common pathways that lead to kidney failure in proteinuric nephropathies. Activation of the complement system has been implicated in the development of tubulointerstitial injury in clinical and animal studies, but the mechanism by which complement induces kidney injury is not fully understood. Here, we studied the effect of complement on the phenotype of tubular epithelial cells. Tubular epithelial cells exposed to serum proteins adopted phenotypic and functional characteristics of mesenchymal cells. Expression of E-cadherin protein decreased and expression of both alpha-smooth muscle actin protein and collagen I mRNA increased. Exposure of the cells to the complement anaphylotoxin C3a induced similar features. Treating with a C3a receptor (C3aR) antagonist prevented both C3a- and serum-induced epithelial-to-mesenchymal transition. In the adriamycin-induced proteinuria model, C3aR-deficient mice demonstrated less injury, preserved renal function, and improved survival compared with wild-type mice. Furthermore, the kidneys of C3aR-deficient mice had significantly less interstitial collagen I and alpha-smooth muscle actin. In summary, the complement anaphylotoxin C3a is an important mediator of glomerular and tubulointerstitial injury and can induce tubular epithelial-to-mesenchymal transition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19158354      PMCID: PMC2653680          DOI: 10.1681/ASN.2008040434

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  54 in total

Review 1.  Complement. Second of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

Review 2.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

3.  Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome.

Authors:  M Nangaku; J Pippin; W G Couser
Journal:  J Am Soc Nephrol       Date:  1999-11       Impact factor: 10.121

4.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.

Authors:  J Yang; Y Liu
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

5.  Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice.

Authors:  M G Robson; H T Cook; M Botto; P R Taylor; N Busso; R Salvi; C D Pusey; M J Walport; K A Davies
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

6.  Role of CD8(+) cells in the progression of murine adriamycin nephropathy.

Authors:  Y Wang; Y P Wang; Y C Tay; D C Harris
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

7.  C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor.

Authors:  P W Peake; S O'Grady; B A Pussell; J A Charlesworth
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

8.  A role for the C3a anaphylatoxin receptor in the effector phase of asthma.

Authors:  A A Humbles; B Lu; C A Nilsson; C Lilly; E Israel; Y Fujiwara; N P Gerard; C Gerard
Journal:  Nature       Date:  2000-08-31       Impact factor: 49.962

9.  Complement activation products in the urine from proteinuric patients.

Authors:  Yoshiki Morita; Hiroshi Ikeguchi; Jiro Nakamura; Nigishi Hotta; Yukio Yuzawa; Seiichi Matsuo
Journal:  J Am Soc Nephrol       Date:  2000-04       Impact factor: 10.121

10.  BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.

Authors:  Michael Zeisberg; Jun-ichi Hanai; Hikaru Sugimoto; Tadanori Mammoto; David Charytan; Frank Strutz; Raghu Kalluri
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

View more
  59 in total

Review 1.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

Review 2.  Review: Complement and its regulatory proteins in kidney diseases.

Authors:  Allison M Lesher; Wen-Chao Song
Journal:  Nephrology (Carlton)       Date:  2010-10       Impact factor: 2.506

3.  Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies.

Authors:  Aleksey Nakorchevsky; Johannes A Hewel; Sunil M Kurian; Tony S Mondala; Daniel Campbell; Steve R Head; Christopher L Marsh; John R Yates; Daniel R Salomon
Journal:  J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 10.121

4.  Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis.

Authors:  Hongmei Gu; Elizabeth A Mickler; Oscar W Cummings; George E Sandusky; Daniel J Weber; Adam Gracon; Trent Woodruff; David S Wilkes; Ragini Vittal
Journal:  FASEB J       Date:  2014-06-23       Impact factor: 5.191

5.  C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis.

Authors:  Runhong Han; Shuai Hu; Weisong Qin; Jinsong Shi; Qin Hou; Xia Wang; Xiaodong Xu; Minchao Zhang; Caihong Zeng; Zhihong Liu; Hao Bao
Journal:  JCI Insight       Date:  2019-04-04

Review 6.  Molecules Great and Small: The Complement System.

Authors:  Douglas R Mathern; Peter S Heeger
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

7.  Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.

Authors:  Hongmei Gu; Amanda J Fisher; Elizabeth A Mickler; Frank Duerson; Oscar W Cummings; Marc Peters-Golden; Homer L Twigg; Trent M Woodruff; David S Wilkes; Ragini Vittal
Journal:  FASEB J       Date:  2016-03-08       Impact factor: 5.191

8.  Renal fibrosis.

Authors:  G Efstratiadis; M Divani; E Katsioulis; G Vergoulas
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

Review 9.  An update on the pathomechanisms and future therapies of Alport syndrome.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

10.  Nitro-oleic acid protects against adriamycin-induced nephropathy in mice.

Authors:  Shanshan Liu; Zhanjun Jia; Li Zhou; Ying Liu; Hong Ling; Shu-Feng Zhou; Aihua Zhang; Yaomin Du; Guangju Guan; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.